Start Date
January 31, 2003
Primary Completion Date
September 30, 2003
Study Completion Date
September 30, 2005
anti-thymocyte globulin
filgrastim
busulfan
cyclophosphamide
cyclosporine
fludarabine phosphate
melphalan
methylprednisolone
umbilical cord blood transplantation
radiation therapy
North Shore University Hospital, Manhasset
James P. Wilmot Cancer Center at University of Rochester Medical Center, Rochester
Children's Hospital of Pittsburgh, Pittsburgh
Duke Comprehensive Cancer Center, Durham
Spectrum Health and DeVos Children's Hospital, Grand Rapids
University of Minnesota Cancer Center, Minneapolis
Children's Mercy Hospital, Kansas City
Children's Hospital of New Orleans, New Orleans
Medical City Dallas Hospital, Dallas
Children's Medical Center of Dallas, Dallas
Texas Transplant Institute, San Antonio
Children's Hospital of Orange County, Orange
City of Hope Comprehensive Cancer Center, Duarte
Children's Hospital Los Angeles, Los Angeles
Jonsson Comprehensive Cancer Center, UCLA, Los Angeles
Children's Medical Center, University of California San Francisco, San Francisco
Children's National Medical Center, Washington D.C.
Indiana University Cancer Center, Indianapolis
Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute, Boston
Cardinal Glennon Children's Hospital, St Louis
Hackensack University Medical Center, Hackensack
Roswell Park Cancer Institute, Buffalo
Ireland Cancer Center, Cleveland
Vanderbilt-Ingram Cancer Center, Nashville
Fred Hutchinson Cancer Research Center, Seattle
National Heart, Lung, and Blood Institute (NHLBI)
NIH
Roswell Park Cancer Institute
OTHER